EP Patent

EP1026149A1 — Amidocarboxylic acid derivatives

Assigned to Sankyo Co Ltd · Expires 2000-08-09 · 26y expired

What this patent protects

Amidocarboxylic acid derivatives of the formula: [wherein R 1 represents a hydrogen atom, etc.; R 2 represents an alkylene group; R 3 represents a hydrogen atom, etc; R 4 represents a hydrogen atom, etc., X represents a substituted or unsubstituted aryl group, etc.; Y repre…

USPTO Abstract

Amidocarboxylic acid derivatives of the formula: [wherein R 1 represents a hydrogen atom, etc.; R 2 represents an alkylene group; R 3 represents a hydrogen atom, etc; R 4 represents a hydrogen atom, etc., X represents a substituted or unsubstituted aryl group, etc.; Y represents an oxygen atom, etc.; Z represents an alkylene group, etc.; and W represents an alkyl group, etc.], pharmacologically acceptable salts thereof and pharmacologically acceptable esters thereof are useful as a therapeutic agent and/or preventive agent for diabetes mellitus, hyperlipemia, arteriosclerosis, hypertension, etc.

Drugs covered by this patent

Patent Metadata

Patent number
EP1026149A1
Jurisdiction
EP
Classification
—
Expires
2000-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.